ClinicalTrials.Veeva

Menu

Platelet Rich Plasma Following Hysteroscopic Adhesolysis

A

Ain Shams University

Status

Completed

Conditions

Intra-uterine Adhesions

Treatments

Procedure: Platelet Rich Plasma
Procedure: intra-uterine balloon

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Platelet Rich Plasma Following Hysteroscopic Adhesolysis: A Randomized Clinical Trial

Enrollment

160 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 18-40 years
  • Grade III intra-uterine adhesions

Exclusion criteria

  • Age < 18 or > 40 years.
  • Hb < 11 g/dL, platelets < 150.000/mm3.
  • Patient taking anticoagulant.
  • Patient taking NSAID in the 10 days before procedure.
  • Any significant comorbidity or psychiatric disorder that would compromise patient's consent.
  • Active cervical or uterine infection.
  • Undiagnosed genital bleeding.
  • pregnancy.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

160 participants in 2 patient groups

Platelet Rich Plasma
Experimental group
Description:
PRP
Treatment:
Procedure: intra-uterine balloon
Procedure: Platelet Rich Plasma
intra-uterine balloon
Active Comparator group
Treatment:
Procedure: intra-uterine balloon

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems